Experts from around the world will gather at the University of Pennsylvania School of Medicine for a special symposium to review the most current research and explore the future of personalized medicine.

Hosted by the Institute for Translational Medicine and Therapeutics, progress and perspectives of personalized medicine will be presented by leaders in the field from the clinical, pharmaceutical, and ethics arenas.

Reporters attending this conference can expect to hear about:

  • Imaging techniques to track response to psychiatric and neurological drugs.
  • The hunt for genes that predispose us to high blood pressure.
  • Childhood leukemia as a model for cancer pharmacogenomics.

For a full agenda and registration, please visit the ITMAT website.

WHEN: Wednesday April, 25 8:00AM – 7:30 PM
WHERE: Biological Research Building Auditorium [map]
University of Pennsylvania School of Medicine
421 Curie Boulevard
Philadelphia PA 19104

Editor’s Note:  Registration is not required if you plan to only attend the Roundtable Session open to the public, which begins at 6:15pm.  For the Roundtable, please contact Molly Reagan for more information:
Phone:  215-898-1188
Email:  mreagan@mail.med.upenn.edu


PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of the University of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $6.7 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2016 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2016, Penn Medicine provided $393 million to benefit our community.